These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Characterization of Protease-Activated Receptor (PAR) ligands: Parmodulins are reversible allosteric inhibitors of PAR1-driven calcium mobilization in endothelial cells. Gandhi DM; Majewski MW; Rosas R; Kentala K; Foster TJ; Greve E; Dockendorff C Bioorg Med Chem; 2018 May; 26(9):2514-2529. PubMed ID: 29685684 [TBL] [Abstract][Full Text] [Related]
25. Discovery of Protease-activated receptor 2 antagonists derived from phenylalanine for the treatment of breast cancer. Kim T; Lee Y; Lim H; Kim Y; Cho H; Namkung W; Han G Bioorg Chem; 2024 Sep; 150():107496. PubMed ID: 38850590 [TBL] [Abstract][Full Text] [Related]
26. Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis. Shi X; Gangadharan B; Brass LF; Ruf W; Mueller BM Mol Cancer Res; 2004 Jul; 2(7):395-402. PubMed ID: 15280447 [TBL] [Abstract][Full Text] [Related]
27. Fully human antibodies against the Protease-Activated Receptor-2 (PAR-2) with anti-inflammatory activity. Giblin P; Boxhammer R; Desai S; Kroe-Barrett R; Hansen G; Ksiazek J; Panzenbeck M; Ralph K; Schwartz R; Zimmitti C; Pracht C; Miller S; Magram J; Litzenburger T Hum Antibodies; 2011; 20(3-4):83-94. PubMed ID: 22129678 [TBL] [Abstract][Full Text] [Related]
28. Diet-induced obesity, adipose inflammation, and metabolic dysfunction correlating with PAR2 expression are attenuated by PAR2 antagonism. Lim J; Iyer A; Liu L; Suen JY; Lohman RJ; Seow V; Yau MK; Brown L; Fairlie DP FASEB J; 2013 Dec; 27(12):4757-67. PubMed ID: 23964081 [TBL] [Abstract][Full Text] [Related]
29. The differential expression of protease activated receptors contributes to functional differences between dark and fair keratinocytes. Xue M; Lin H; Zhao R; Liang HP; Jackson C J Dermatol Sci; 2017 Mar; 85(3):178-185. PubMed ID: 27979585 [TBL] [Abstract][Full Text] [Related]
30. Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2. Mize GJ; Wang W; Takayama TK Mol Cancer Res; 2008 Jun; 6(6):1043-51. PubMed ID: 18567807 [TBL] [Abstract][Full Text] [Related]
31. Activity of protease-activated receptors in the human submucous plexus. Mueller K; Michel K; Krueger D; Demir IE; Ceyhan GO; Zeller F; Kreis ME; Schemann M Gastroenterology; 2011 Dec; 141(6):2088-2097.e1. PubMed ID: 21875497 [TBL] [Abstract][Full Text] [Related]
32. Genetic targeting of protease activated receptor 2 reduces inflammatory astrogliosis and improves recovery of function after spinal cord injury. Radulovic M; Yoon H; Wu J; Mustafa K; Fehlings MG; Scarisbrick IA Neurobiol Dis; 2015 Nov; 83():75-89. PubMed ID: 26316358 [TBL] [Abstract][Full Text] [Related]
33. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides. Hollenberg MD; Saifeddine M; al-Ani B; Kawabata A Can J Physiol Pharmacol; 1997 Jul; 75(7):832-41. PubMed ID: 9315351 [TBL] [Abstract][Full Text] [Related]
34. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells. Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244 [TBL] [Abstract][Full Text] [Related]
35. Role of proteinase-activated receptors 1 and 2 in nonsteroidal anti-inflammatory drug enteropathy. Fornai M; Colucci R; Pellegrini C; Benvenuti L; Natale G; Ryskalin L; Blandizzi C; Antonioli L Pharmacol Rep; 2020 Oct; 72(5):1347-1357. PubMed ID: 32583327 [TBL] [Abstract][Full Text] [Related]
37. Biomolecular evidence of anti-inflammatory effects by Clematis mandshurica Ruprecht root extract in rodent cells. Lee CW; Park SM; Kim YS; Jegal KH; Lee JR; Cho IJ; Ku SK; Lee JY; Ahn YT; Son Y; Ju SA; Kim SC; An WG J Ethnopharmacol; 2014 Sep; 155(2):1141-55. PubMed ID: 24975194 [TBL] [Abstract][Full Text] [Related]
38. Binding of a highly potent protease-activated receptor-2 (PAR2) activating peptide, [3H]2-furoyl-LIGRL-NH2, to human PAR2. Kanke T; Ishiwata H; Kabeya M; Saka M; Doi T; Hattori Y; Kawabata A; Plevin R Br J Pharmacol; 2005 May; 145(2):255-63. PubMed ID: 15765104 [TBL] [Abstract][Full Text] [Related]